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cResults of a Prospective, Multicenter Trial With the Ventana Fenes-
trated System for Endovascular Repair of Juxtarenal and Pararenal
Aortic Aneurysms
William Quinones-Baldrich, MD,1 Andrew Holden,2 Renato Mortens,3
Matt Thompson,4 Alan Sawchuck,5 Mathew Eagleton, MD,6 and
Daniel Clair, MD6. 1Division of Vascular Surgery, University of California–
Los Angeles Medical Center, Los Angeles, Calif; 2Auckland City Hospital,
Auckland, New Zealand; 3Escuela de Medicina, Pontificia Universidad
CatÃlica de Chile, Santiago, Chile; 4St. George’s Institute, London, United
Kingdom; 5Methodist Hospital, Indianapolis, Ind; and 6Cleveland Clinic
Foundation, Cleveland, Ohio
Objective: This study assessed early and midterm safety and efficacy of
an off-the-shelf endovascular graft system (Ventana) in patients with para-
renal or juxtarenal aneurysms.
Methods: After Institutional Review Board approval, patients with
infrarenal aneurysms adjacent to or involving the origin of one or both
renal arteries were evaluated. Selection criteria included adequate access,
nonaneurysmal infrasuperior mesenteric artery neck length15 mm, and
renal stenosis 70%. Evaluation was done at discharge, 1, 6 months, 1
year, and annually to 5 years. Core laboratory computed tomography
evaluation was done for assessment of device integrity, patency, migra-
tion, endoleak, renal perfusion, and aneurysm morphology.
Results: Between 2010 and 2012, six centers enrolled 30 consecu-
tive patients with juxtarenal or pararenal aortic aneurysm. Patients (90%
men; mean age, 73 years) had a mean aneurysm sac diameter of 5.8 cm,
infrarenal neck length of 6 mm, and infrasuperior mesenteric artery neck
diameter of 24 mm and length of 26 mm. A Ventana graft system with
covered renal stents was implanted, preserving all visceral arteries. Com-
plications included a compressed renal stent due to repeat ballooning and
one extended renal cannulation time due to renal stenosis not seen on the
computed tomography scan. Procedure time averaged 2  1.5 hours.
Mean hospital stay was 3.8 days. No deaths occurred 30 days. One
intervention on day 26 for limb occlusion was due to device kink. Three
non-aneurysm-related deaths occurred during follow-up (mean, 8
months; range, 1-16 months). No rupture, conversion, stent fracture,
migration, type III endoleak, or sac expansion was observed. Small type
II endoleak was observed in six patients at 1 month and in three patients
at 6 months. One reintervention for renal stenosis due to initial renal
stent undersizing was done at 7 months. A type IA endoleak and renal
occlusion, secondary to procedural device damage, led to reintervention
on day 52 and dialysis at 5 months.
Conclusions: The multicenter experience of the Ventana Fenes-
trated System supports its safety and midterm effectiveness for the
endovascular repair of juxtarenal and pararenal aortic aneurysm. This
off-the-shelf, integrated system permits endovascular treatment of jux-
tarenal or pararenal aortic aneurysms; however, further expanded clinical
experience and longer-term follow-up are needed to more fully assess this
device system.
“Preloaded” Modification to the Trifurcated Technique for Hypogas-
tric Preservation During Aortoiliac Endovascular Aneurysm Repair
Without Device Alteration
Jason T. Lee, MD,1 Joshua I. Greenberg, MD,1 Mark A. Farber, MD,2 and
E. John Harris, Jr, MD1. 1Division of Vascular Surgery, Stanford University
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Objective: Due to lack of commercially available iliac branched
devices, there have been descriptions of trifurcated techniques, home-
made branch devices, and the double-barrel/snorkel approach to pre-
serve hypogastric flow during endovascular aneurysm repair. We describe
a novel technique mimicking a “preloaded” catheter to provide through-
and-through wire access that eliminates the anatomic length restrictions
of the aforementioned techniques, obviates the need for arm access, and
can be performed without device modification.
Methods: A 78-year-old man with comorbid factors of prior stroke
after an emergency coronary artery bypass grafting procedure was found to
have a 5-cm abdominal aortic aneurysm with bilateral 4-cm iliac aneurysms
and desired an endovascular solution (Fig, A).
Results: After R hypogastric embolization, a Gore C3 main body (23
12  120) was deployed into the left common iliac (Fig, B). The introducer
sheath was doubly accessed, and a 4F glide catheter/wire was advanced
alongside the distal portion of the undeployed ipsilateral limb into the
left iliac aneurysm (black arrow). The contralateral gate of the C3 was
catheterized to mimic a “preloaded” catheter (Fig, C). The wire was
snared from the right and pulled out the right femoral sheath, providing
through-and-through wire stability over the aortic bifurcation. A 12F
sheath could then be easily advanced up and over and out the contralat-
eral gate of the C3 device, pointed at the hypogastric origin (Fig, D). The
through-and-through wire and 12F sheath were left in place, and a
shaped 7F sheath was advanced via a buddy wire/catheter (white arrow)
into the left hypogastric (Fig, E). This triaxial strategy allowed easy
advancement, positioning, and molding of a 10  59 iCast stent with a
a
a
5784  40 balloon spanning the contralateral gate to the distal hypogastric
anding zone (Fig, F). Once this “iliac branch device” was in place, a main
ody C3 was deployed infrarenal from the right side, and a bridging
7-mm limb from the left joined the two main bodies. Completion
ngiography confirmed no endoleak (Fig, G). and a postoperative com-
uted tomography angiography demonstrated complete exclusion.
Conclusions: The modification of placing a “preloaded” catheter
hrough the contralateral gate of the C3 repositionable main body
eployed in the common iliac effectively creates an iliac branch device.
ong-term follow-up will be necessary to confirm that this approach is
urable and effective without the need for second interventions.
hysician-Modified Endovascular Grafts: Early Report From an
nvestigator-Initiated Investigational Device Exemption Clinical
rial
enjamin W. Starnes, MD, and Billi Tatum, RN. Department of Surgery,
niversity of Washington, Seattle, Wash
Objective: This study determined whether a physician-modified endo-
ascular graft (PMEG) is a safe and effective method for treating patients
ith juxtarenal aortic aneurysms who are deemed unsuitable for open
urgical repair.
Methods: This nonrandomized, prospective, consecutively enroll-
ng investigational device exemption clinical trial was approved by the
nited States Food and Drug Administration. Data collected on patients
reated with a PMEG between the initiation of the study in April 2011
nd January 2012 were analyzed. All patients met strict inclusion and
xclusion criteria as defined by the study protocol. All patients underwent
reoperative computed tomography angiography and visceral duplex
xaminations. Participants were monitored with computed tomography,
isceral duplex imaging, and 4-view X-ray imaging at 30 days, 6 months,
year, and annually out to 5 years. The primary safety end point was
efined as the proportion of participants who experienced a major
dverse event 30 days of the procedure. The primary effectiveness end
oint was defined as the proportion of participants experiencing treat-
ent success.
Results: During the 8-month study period, 21 patients were con-
ented and 18 underwent the PMEG procedure. Eighteen patients had
0-day follow-up, eight had 6-month follow-up, and none had 1-year
ollow up. Seventy-four percent of the participants were male. Anatomic,
perative details, and length of stay are listed in the Table. There were 47
enestrations created for 34 renal arteries and 13 superior mesenteric
rteries (SMA). Renal artery fenestrations were stented whenever possi-
le (94%), and SMA fenestrations were left unstented. There were no
nanticipated adverse device events, no major adverse device events, and
nly one minor adverse device event, which was treated with a successful
eintervention. At 30 days, there were no type I or III endoleaks and only
wo type II endoleaks. Two patients died during the study period, one at
ay 23 from respiratory failure, and one at day 210 from urosepsis and
ongestive heart failure.
Conclusions: These preliminary data suggest that PMEG is a safe
Fig.nd effective procedure for managing patients with juxtarenal aortic
neurysms. PMEG has acceptable early rates of morbidity, mortality, and
